Is the Allergan patent deal a misuse of sovereign immunity?

19-09-2017

Is the Allergan patent deal a misuse of sovereign immunity?

miodrag ignjatovic / iStockphoto.com

Earlier this month, in a bid to obtain immunity against an inter partes review (IPR), Allergan transferred its patent rights for a dry eye treatment to a Native American tribe.


Allergan, Saint Mohawk Tribe, Restasis, patent, patent agreement, Native Americans, eye treatment, inter partes review, sovereign immunity, Mylan

LSIPR